IDEXX Laboratories

World Rank (Jan-05-2024)

393

Market Cap (Jan-05-2024)

44.723 Billion USD

World Rank (Jul-30-2023)

386

Market Cap (Jul-30-2023)

45.883 Billion USD

World Rank (Jan-07-2022)

415

Market Cap (Jan-07-2022)

46.662 Billion USD

World Rank (Jan-01-2021)

395

Market Cap (Jan-01-2021)

42.639 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 188

Headquarters Country

USA

Nasdaq / NYSE Code

IDXX

Market Cap (Mar-08-2026)

48.44

CEO

Jay Mazelsky

Chairman

Jonathan W. Ayers

Employee Count

10,780

Employee Count as of Date

As on 2022

Headquarters City/State

Maine

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

3,367 Million USD

Annual Operating Income in USD

898 Million USD

Annual Net Income in USD

679 Million USD

Annual Results for Period Ending

Dec-2022 ending year

Total Assets in USD

2,746 Million USD

Total Liabilities in USD

2,138 Million USD

Total Equity in USD

608 Million USD

Balance Sheet for Period Ending

Dec-2022 ending year

Business Sector

Healthcare

HealthCare Products

Pharmaceutical

Animal Health Medicine

Animal Healthcare Companies

Company Website

Idexx - Animal Healthcare Company

Wikipedia

Yahoo

Yahoo @ Nasdaq

Facebook

Company Profile

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world. Headquarters is in USA.

Idexx is animal healthcare company and they have over 7,000 employees across 175 countries.

Idexx Laboratories engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.

Idexx have board-certified veterinary specialists and pathologists and they early detect issues and health disorders in animals.

As on 2022, IDEXX Laboratories, Inc. has 10,780 employees.

IDEXX Laboratories, Inc. annual revenue generated for period ending Dec-2022 was 3,367 million USD.

IDEXX Laboratories, Inc. annual net income generated for period ending Dec-2022 was 679 million USD.

IDEXX Laboratories annual revenue generated for period ending Dec-2021 was 3,215 million USD.

IDEXX Laboratories annual net income generated for period ending Dec-2021 was 744 million USD.

Annual Results Summary

IDEXX LABORATORIES - Annual Result Summary - in Million USD

Year Ending:	Total Revenue	Operating Income	Net Income
Dec-2023	3,660	1,097	845
Dec-2022	3,367	898	679
Dec-2021	3,215	932	744
Dec-2020	2,706	694	582
Dec-2019	2,407	553	428
Dec-2018	2,213	491	377
Dec-2017	1,969	413	263
Dec-2016	1,775	350	222

Balance Sheet Summary

IDEXX LABORATORIES - Balance Sheet Summary - in Million USD

Year Ending:	Total Assets	Total Liabilities	Total Equity
Dec-2023	3,259	1,775	1,484
Dec-2022	2,746	2,138	608
Dec-2021	2,437	1,747	690
Dec-2020	2,295	1,662	632
Dec-2019	1,832	1,655	177
Dec-2018	1,537	1,547	-10
Dec-2017	1,713	1,768	-54

Founded Year

1983

Institutional Investors

Top 30 Institutional Holder Names in IDEXX LABORATORIES as on SEP-30-2023

RANK	INSTITUTION NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	BLACKROCK INC.	09/30/2023	86,34,291	-14,459	-0.17%	$4,029,106
2	VANGUARD GROUP INC	09/30/2023	82,60,460	14,365	0.17%	$3,854,661
3	STATE STREET CORP	09/30/2023	37,62,070	-9,504	-0.25%	$1,755,532
4	ALLIANCEBERNSTEIN L.P.	09/30/2023	33,26,016	-2,66,816	-7.43%	$1,552,052
5	FUNDSMITH LLP	09/30/2023	29,64,554	3,003	0.10%	$1,383,379
6	BAMCO INC /NY/	09/30/2023	23,36,330	-40,302	-1.70%	$1,090,225
7	GEODE CAPITAL MANAGEMENT, LLC	09/30/2023	20,64,139	51,140	2.54%	$963,210
8	FRANKLIN RESOURCES INC	09/30/2023	13,77,349	-69,666	-4.81%	$642,726
9	INVESCO LTD.	09/30/2023	12,16,978	-19,107	-1.55%	$567,891
10	BLAIR WILLIAM & CO/IL	09/30/2023	11,99,945	7,812	0.66%	$559,942
11	BROWN ADVISORY INC	09/30/2023	11,61,124	24,741	2.18%	$541,827
12	MORGAN STANLEY	09/30/2023	10,64,514	48,095	4.73%	$496,745
13	CAPITAL WORLD INVESTORS	09/30/2023	10,11,327	4,254	0.42%	$471,926
14	FUNDSMITH INVESTMENT SERVICES LTD.	09/30/2023	9,89,592	-29,936	-2.94%	$461,783
15	GQG PARTNERS LLC	09/30/2023	9,31,886	9,31,886	New	$434,855
16	NORTHERN TRUST CORP	09/30/2023	9,19,191	65,891	7.72%	$428,931
17	NORGES BANK	12/31/2022	8,24,629	35,899	4.55%	$384,805
18	PRINCIPAL FINANCIAL GROUP INC	09/30/2023	8,15,863	11,315	1.41%	$380,714
19	JPMORGAN CHASE & CO	09/30/2023	8,01,274	65,760	8.94%	$373,906
20	BANK OF AMERICA CORP /DE/	09/30/2023	7,95,957	1,27,793	19.13%	$371,425
21	AMERICAN CENTURY COMPANIES INC	09/30/2023	7,34,707	-1,03,948	-12.40%	$342,844
22	WINSLOW CAPITAL MANAGEMENT, LLC	09/30/2023	6,89,873	1,37,621	24.92%	$321,922
23	LEGAL & GENERAL GROUP PLC	09/30/2023	6,72,039	-22,921	-3.30%	$313,600
24	BANK OF NEW YORK MELLON CORP	09/30/2023	6,61,371	-4,684	-0.70%	$308,622
25	AMUNDI	09/30/2023	6,12,065	29,589	5.08%	$285,614
26	GOLDMAN SACHS GROUP INC	09/30/2023	5,42,236	44,395	8.92%	$253,029
27	UBS ASSET MANAGEMENT AMERICAS INC	09/30/2023	5,04,789	87,185	20.88%	$235,555
28	NEUBERGER BERMAN GROUP LLC	09/30/2023	4,87,846	-7,221	-1.46%	$227,648
29	CAPITAL COUNSEL LLC/NY	09/30/2023	4,72,270	-727	-0.15%	$220,380
30	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	09/30/2023	4,62,535	5,044	1.10%	$215,837